Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
3.210
+0.120 (3.88%)
Jan 15, 2025, 10:27 AM EST - Market open
Leap Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
54
Market Cap
123.00M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 393.90B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
LPTX News
- 9 days ago - Leap Therapeutics: A Buy On Near-Term Data Catalysts In Stomach And Colon Cancer - Seeking Alpha
- 9 days ago - Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 7 weeks ago - Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 2 months ago - Leap Therapeutics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients - PRNewsWire
- 5 months ago - Leap Therapeutics Reports Second Quarter 2024 Financial Results - PRNewsWire
- 8 months ago - Leap Therapeutics Reports First Quarter 2024 Financial Results - PRNewsWire
- 9 months ago - Leap Therapeutics Announces $40 Million Private Placement - PRNewsWire